Innovative Medical Management Co.,Ltd. (SHE:002173)
China flag China · Delayed Price · Currency is CNY
17.67
-0.66 (-3.60%)
Aug 24, 2026, 3:04 PM CST

SHE:002173 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
-78.36-34.85-93.95-34.29-73.42-103.46
Depreciation & Amortization
94.0492.1101.94106.66110.26115.76
Other Amortization
10.9610.96.646.369.499.97
Loss (Gain) From Sale of Assets
-0.03-0.021.42-1.061.16-0.06
Asset Writedown & Restructuring Costs
5.333.053.395.2611.61.24
Loss (Gain) From Sale of Investments
-40.06-36.93-1.981.84-2.66-15.84
Provision & Write-off of Bad Debts
-3.98-3.982.423.35-2.333.52
Other Operating Activities
2.632.464.33.633.75-3.19
Change in Accounts Receivable
4.9639-27.79-49.0735.9911.69
Change in Inventory
9.395.93-0.476.82-6.7-8.01
Change in Accounts Payable
-24.45-10.81-1.542.39-18.0619.15
Change in Other Net Operating Assets
2.832.546.54-37.7-91.8316.5
Operating Cash Flow
-10.2875.93-7.3411.03-24.4543.37
Operating Cash Flow Growth
------67.06%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-47.63-84.52-46.95-96.24-123.18-110.72
Sale of Property, Plant & Equipment
0.20.10.080.340.290.15
Cash Acquisitions
-1.07-1.07---0.6-1.68
Divestitures
--3.88-0.7737.3
Investment in Securities
61.6187.94-87.32-3205655
Other Investing Activities
--0.090.5517.7317.57
Investing Cash Flow
13.112.45-129.92-415.34460.01-52.39

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Short-Term Debt Issued
----233
Long-Term Debt Issued
-23.0153.9131.16--
Total Debt Issued
50.0123.0153.9131.16233
Short-Term Debt Repaid
-----12-33
Long-Term Debt Repaid
--29.51-45.57-34.67-13.18-30.66
Total Debt Repaid
-26.51-29.51-45.57-34.67-25.18-63.66
Net Debt Issued (Repaid)
23.5-6.58.34-3.51-2.18-60.66
Repurchase of Common Stock
----0--48.4
Common Dividends Paid
-2.6-2.59-2.59-1.46-0.79-2.35
Other Financing Activities
-51.43-----
Financing Cash Flow
-30.53-9.095.75-4.98-2.97-111.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Cash Flow
-27.769.29-131.52-409.29432.59-120.43

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
-57.91-8.59-54.3-85.21-147.62-67.35
Free Cash Flow Growth
------
Free Cash Flow Margin
-8.07%-1.10%-6.65%-10.58%-20.80%-9.47%
Free Cash Flow Per Share
-0.12-0.02-0.12-0.20-0.33-0.15
Levered Free Cash Flow
-30.78-14.56-13.73-55.2-65.25-44.18
Unlevered Free Cash Flow
-28.4-12.17-11.18-52.92-63.15-40.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
14.6615.1413.0812.197.7716.35
Change in Working Capital
-0.8243.2-31.51-80.72-82.2935.42